| 2025 | 2024 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47,6 M € | -6.5% | 50,9 M € | +8.4% | 46,9 M € | +12.2% | 41,8 M € | +2.9% | 40,6 M € | +51.0% | 26,9 M € | +9.4% | 24,6 M € | +4.9% | 23,5 M € | +1.2% | 23,2 M € | +10.8% | 20,9 M € | -0.5% | 21,0 M € | +8.2% | 19,5 M € | +16.9% | 16,6 M € | +35.2% | 12,3 M € | +1.0% | 12,2 M € | +13.8% | 10,7 M € | |
| EBITDA | 5,4 M € | -25.9% | 7,2 M € | +9.4% | 6,6 M € | +18.5% | 5,6 M € | -20.9% | 7,1 M € | +109.7% | 3,4 M € | +6.2% | 3,2 M € | +1.6% | 3,1 M € | +0.8% | 3,1 M € | -5.8% | 3,3 M € | -15.6% | 3,9 M € | +26.4% | 3,1 M € | +397.5% | -1,0 M € | -135.8% | 2,9 M € | +112.4% | 1,4 M € | +279.2% | 359,1 k € | |
| Operating profit | 2,6 M € | -43.0% | 4,6 M € | +20.4% | 3,8 M € | +3.3% | 3,7 M € | -32.3% | 5,5 M € | +167.4% | 2,0 M € | +4.9% | 2,0 M € | -0.9% | 2,0 M € | -7.8% | 2,1 M € | -11.3% | 2,4 M € | -28.2% | 3,4 M € | +31.2% | 2,6 M € | +232.2% | -1,9 M € | -180.4% | 2,4 M € | +155.9% | 939,3 k € | +551.9% | 144,1 k € | |
| Profit/loss | 1,6 M € | -42.8% | 2,7 M € | +20.7% | 2,3 M € | -4.2% | 2,4 M € | -49.5% | 4,7 M € | +270.6% | 1,3 M € | +8.8% | 1,2 M € | +0.4% | 1,2 M € | -11.2% | 1,3 M € | -17.2% | 1,6 M € | -29.4% | 2,2 M € | -0.1% | 2,2 M € | +215.0% | -1,9 M € | -230.3% | 1,5 M € | +143.3% | 608,5 k € | +484.1% | 104,2 k € | |
| Equity | 7,7 M € | -15.8% | 9,1 M € | +8.6% | 8,4 M € | -0.5% | 8,4 M € | +0.7% | 8,4 M € | +288.5% | 2,2 M € | +13.5% | 1,9 M € | +8.9% | 1,7 M € | -5.4% | 1,8 M € | +28.2% | 1,4 M € | -49.9% | 2,9 M € | -21.4% | 3,7 M € | +154.3% | 1,4 M € | -57.3% | 3,4 M € | +78.4% | 1,9 M € | +47.6% | 1,3 M € | |
| Total assets | 31,6 M € | -5.3% | 33,4 M € | +7.9% | 31,0 M € | -3.6% | 32,1 M € | +21.5% | 26,4 M € | +60.3% | 16,5 M € | +9.8% | 15,0 M € | +1.4% | 14,8 M € | +17.4% | 12,6 M € | +8.6% | 11,6 M € | -9.4% | 12,8 M € | +8.0% | 11,9 M € | +23.4% | 9,6 M € | -7.3% | 10,4 M € | +27.2% | 8,2 M € | +6.2% | 7,7 M € | |
| Cash | 59,7 k € | -5.8% | 63,4 k € | +40.9% | 45,0 k € | -12.1% | 51,2 k € | +31.7% | 38,8 k € | -92.3% | 506,0 k € | +80.1% | 280,9 k € | +9.0% | 257,8 k € | +94.7% | 132,4 k € | -85.0% | 883,7 k € | -56.4% | 2,0 M € | +23.3% | 1,6 M € | +170.1% | 608,1 k € | +1000.2% | 55,3 k € | -24.6% | 73,3 k € | -46.2% | 136,2 k € | |
| Debts | 14,2 M € | -6.3% | 15,2 M € | +11.7% | 13,6 M € | -10.2% | 15,1 M € | +61.9% | 9,3 M € | +31.3% | 7,1 M € | +20.4% | 5,9 M € | -1.6% | 6,0 M € | +54.8% | 3,9 M € | -1.6% | 3,9 M € | -9.8% | 4,4 M € | +34.1% | 3,3 M € | -8.0% | 3,5 M € | +53.3% | 2,3 M € | +21.7% | 1,9 M € | -20.8% | 2,4 M € | |
| Staff | 191,9 | 192,7 | 200,3 | 177,2 | 163,4 | 112,2 | 91,9 | 84,9 | 80,3 | 70,5 | 67,2 | 59,9 | 52,8 | 50 | 44,6 | 38,9 | ||||||||||||||||
Public limited company · Dilbeek · incorporated on 05/12/1978 · 191,9 ETP
Public limited company profitable and well capitalised. Cash position declining (-5.8%).
Solid counterparty for a standard engagement.
Amplifon Belgium is a Public limited company incorporated in 1978. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Dilbeek. It employs on average 191,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette